Lexeo Therapeutics, Inc.’s LXEO share price has dipped by 6.54%, which has investors questioning if this is right time to buy ...

Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) (“Coeptis” or the “Company”), a biopharmaceutical and technology company focused on developing innovative cell therapy platforms for cancer, ...

ORION CORPORATION PRESS RELEASE 25 APRIL 2025 at 9.00 EEST Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson's ...